Ware Olivia C Insider Trades

Insider Trading History

Track insider trading activity for Ware Olivia C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Arcellx
Arcellx ACLX
Director
Holding Value $0 0 shares
Last Trade
Apr 28, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.53M 65,450 shares
$115.07
$115.07
Contineum Therapeutics
Contineum Therapeutics CTNM
Director
Holding Value $176k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$11.91
Arcellx
Arcellx ACLX
Director
Holding Value $1.06M 9,174 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$584k 9,174 shares
$63.68
$115.07
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $0 0 shares
Last Trade
Feb 06, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$54.8k 15,000 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $54.8k 15,000 shares
Last Trade
Feb 04, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$60.9k 16,675 shares
$3.65
$3.65
Arcellx
Arcellx ACLX
Director
Holding Value $922k 8,011 shares
Last Trade
May 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$411k 8,011 shares
$51.30
$115.07
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $116k 31,675 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.1k 23,458 shares
$3.80
$3.65
Arcellx
Arcellx ACLX
Director
Holding Value $1.08M 9,402 shares
Last Trade
Apr 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$519k 9,402 shares
$55.22
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $4.24M 36,806 shares
Last Trade
Apr 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$519k 9,402 shares
$55.22
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $301k 2,612 shares
Last Trade
Apr 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$522k 9,402 shares
$55.55
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $817k 7,100 shares
Last Trade
Mar 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$634k 9,000 shares
$70.40
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $5.32M 46,208 shares
Last Trade
Mar 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$636k 9,000 shares
$70.62
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $1.04M 9,000 shares
Last Trade
Mar 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$636k 9,000 shares
$70.62
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $1.32M 11,459 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$435k 11,459 shares
$37.94
$115.07
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $60.9k 16,675 shares
Last Trade
May 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$199k 5,915 shares
$33.61
$3.65
Arcellx
Arcellx ACLX
Director
Holding Value $6.35M 55,208 shares
Last Trade
May 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$840k 110,416 shares
$7.61
$115.07
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $48k 13,141 shares
Last Trade
May 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$315k 17,402 shares
$18.12
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $39.3k 10,756 shares
Last Trade
May 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 10,756 shares
$18.12
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $25.8k 7,082 shares
Last Trade
May 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.2k 1,942 shares
$27.91
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $40.7k 11,161 shares
Last Trade
Mar 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422k 17,569 shares
$24.03
$3.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up